Table 1.
Demographic and clinical characteristics of patients with and without RD.
| Without RD (n = 38; Mean ± SD) | RD (n = 39; Mean ± SD) | Value of p | |
|---|---|---|---|
| Age (years) | 51.71 ± 8.44 | 55.00 ± 8.53 | 0.093 |
| Gender (female/male) | 27/11 | 34/5 | 0.081 |
| Education (years) | 11.18 ± 3.20 | 10.00 ± 3.42 | 0.121 |
| MoCA | 28.05 ± 1.37 | 27.79 ± 1.22 | 0.386 |
| HAMA | 7.39 ± 2.11 | 8.36 ± 2.43 | 0.068 |
| HAMD | 8.08 ± 2.27 | 9.10 ± 3.07 | 0.101 |
| Affected side (left/right) | 22/16 | 18/21 | 0.303 |
| Before successful CRM | |||
| Duration of vertigo (days) | 2.86 ± 2.36 | 4.63 ± 3.11 | 0.006 |
| VVAS | 5.76 ± 2.06 | 6.59 ± 2.19 | 0.092 |
| DHI | 38.08 ± 11.60 | 46.64 ± 15.74 | 0.008 |
| After successful CRM | |||
| Duration of dizziness (days) | / | 22.41 ± 15.14 | / |
| DVAS | / | 2.95 ± 1.02 | / |
| DHI | / | 25.08 ± 10.33 | / |
RD, Residual dizziness; MoCA, Montreal cognitive assessment scale; HAMA, Hamilton anxiety scale; HAMD, Hamilton depression scale; CRM, Canalith repositioning maneuvers; VVAS, Vertigo visual analog scale; DHI, Dizziness handicap inventory; DVAS, Dizziness visual analog scale.